Center Laboratories, Inc. (TPEX:4123)

Taiwan · Delayed Price · Currency is TWD

39.75

-0.65 (-1.61%)

Apr 20, 2026, 1:24 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Adjustment and Write-Off	-24.26M	-21.57M	-18.72M	-1.52M	-1.64M
Pharmaceutical Division	941.10M	971.71M	950.53M	767.80M	500.31M
Pharmaceutical Division Growth	-3.15%	2.23%	23.80%	53.47%	-16.77%
Shengzhi Venture	23.17M	20.82M	16.14M	-	-
Shengzhi Venture Growth	11.29%	29.00%	-	-	-
Fenghua Sector/Department	576.17M	646.91M	446.06M	-	-
Fenghua Sector/Department Growth	-10.93%	45.03%	-	-	-
Other Department	-	-	-	1.44M	1.44M
Other Department Growth	-	-	-	0%	0.07%
Total	1.52B	1.62B	1.39B	767.72M	500.11M
Total Growth	-6.28%	16.06%	81.58%	53.51%	-30.25%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	1.17B	1.18B	1.08B	767.72M	500.11M
Taiwan Growth	-0.46%	8.65%	40.97%	53.51%	-20.72%
China	322.43M	406.56M	297.06M	-	-
China Growth	-20.69%	36.86%	-	-	-
Others	23.37M	35.51M	14.72M	-	-
Others Growth	-34.19%	141.33%	-	-	-
Total	1.52B	1.62B	1.39B	767.72M	500.11M
Total Growth	-6.28%	16.06%	81.58%	53.51%	-30.25%

Source: S&P Global Market Intelligence.